Clarification of the use of rivaroxaban in renal patients.

Kenneth Todd Moore

Published in: British journal of haematology (2018)

Keyphrases

end stage renal disease
ejection fraction
venous thromboembolism
atrial fibrillation
prognostic factors
pulmonary embolism